| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/28/2008 | WO2008024391A1 Pharmaceutical formulations of an indole-type derivative and related methods of use |
| 02/28/2008 | WO2008024389A2 Amphiphilic nucleotide cochleate compositions and methods of using the same |
| 02/28/2008 | WO2008024141A2 Nanofiber structures on asperities for sequestering, carrying and transferring substances |
| 02/28/2008 | WO2008024045A1 Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate |
| 02/28/2008 | WO2008024044A1 Compositions, suitable for oral administration, comprising a triazolo [4, 5] pyrimidin derivate |
| 02/28/2008 | WO2008024021A1 Antioxidant for preventing and treating diseases caused by oxidative stress |
| 02/28/2008 | WO2008024020A1 Liposomal composition of antioxidants for inhalations carried out during lung and upper respiratory tract diseases |
| 02/28/2008 | WO2008024006A2 Pharmaceutical preparation in a gel form |
| 02/28/2008 | WO2008023999A1 A composition to improve delivery of an active agent |
| 02/28/2008 | WO2008023958A1 Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023807A1 Stabilized pharmaceutical composition |
| 02/28/2008 | WO2008023784A1 Agent for amelioration of ophthalmic circulatory disorder |
| 02/28/2008 | WO2008023384A1 Propofol emulsion compositions for intravenous administration |
| 02/28/2008 | WO2008023300A1 Drug delivery device with piezoelectric actuator |
| 02/28/2008 | WO2008023261A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 02/28/2008 | WO2008023237A2 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera) |
| 02/28/2008 | WO2008023233A1 Formulations for antigen-specific tolerance induction |
| 02/28/2008 | WO2008023184A2 Solid dosage form |
| 02/28/2008 | WO2008023064A2 Use of a composition for skin treatment during x-ray irradiation |
| 02/28/2008 | WO2008023027A2 Process for preparing pramipexole dihydrochloride tablets with high storage stability |
| 02/28/2008 | WO2008023016A2 Galenic formulations of aliskiren |
| 02/28/2008 | WO2008022932A2 Controlled release system and method for manufacturing the same |
| 02/28/2008 | WO2008022557A1 Liquid composition of sirolimus |
| 02/28/2008 | WO2008006535A3 Use of a cationic colloidal preparation for the diagnosis and treatment of ocular diseases |
| 02/28/2008 | WO2008006235A3 Scfv antibodies which pass epithelial and/or endothelial layers |
| 02/28/2008 | WO2008000448A3 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles |
| 02/28/2008 | WO2007147125A3 Tetracycline package formulations |
| 02/28/2008 | WO2007117581A3 Stabilized transdermal bupropion preparations |
| 02/28/2008 | WO2007113857A3 Modified release clopidogrel formulation |
| 02/28/2008 | WO2007109357A3 Controlled release formulation of tolterodine |
| 02/28/2008 | WO2007103511B1 Multi-layer medical patch with impermeable center |
| 02/28/2008 | WO2007097818A3 Antimicrobial cellulosic sheet |
| 02/28/2008 | WO2007052289B1 Novel dispersible tablet composition |
| 02/28/2008 | WO2006125153A3 Formulations for alteration of biophysical properties of mucosal lining |
| 02/28/2008 | WO2004100860A3 Stable liposomes for microencapsulation of animal venoms |
| 02/28/2008 | US20080051766 Method for Operating Microchip Reservoir Device |
| 02/28/2008 | US20080051765 Systems and methods allowing for reservoir filling and infusion medium delivery |
| 02/28/2008 | US20080051691 Implantable shunt or catheter enabling gradual delivery of therapeutic agents |
| 02/28/2008 | US20080051561 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080051490 Medical Devices and Applications of Polyhydroxyalkanoate Polymers |
| 02/28/2008 | US20080051460 Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050450 Active Agent Formulations, Methods of Making, and Methods of Use |
| 02/28/2008 | US20080050449 Controlled release formulation of tolterodine |
| 02/28/2008 | US20080050448 Antimicrobial conjugates |
| 02/28/2008 | US20080050447 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080050446 Fast Release Dosage Forms for Antibiotics |
| 02/28/2008 | US20080050445 Niosome-Hydrogel Drug Delivery |
| 02/28/2008 | US20080050444 Pharmaceutical compositions of ilaparazole |
| 02/28/2008 | US20080050443 Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing Thereof |
| 02/28/2008 | US20080050442 Nasal pharmaceutical formulations and methods of using the same |
| 02/28/2008 | US20080050441 Process for the preparation of solid sterile active pharmaceutical ingredient |
| 02/28/2008 | US20080050440 Plant epidemic prevention agent, plant epidemic prevention method, plant epidemic prevention system, plant, and plant cultivation method |
| 02/28/2008 | US20080050439 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/28/2008 | US20080050438 Dry compositions |
| 02/28/2008 | US20080050437 a time-release composition comprising antithrombins such as (2S)-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-N-[[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]methyl]azetidine-2-carboxamide, hydroxy propyl methyl cellulose and sodium stearyl fumarate as a lubricant; cardiovascular disorder |
| 02/28/2008 | US20080050436 Methods and compounds for obliteration of vessels |
| 02/28/2008 | US20080050435 Temperature Sensitive Polymers |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |
| 02/28/2008 | US20080050432 Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors |
| 02/28/2008 | US20080050431 Sustained release formulations of oxymorphone |
| 02/28/2008 | US20080050430 Pharmaceutical compositions and methods for improved bacterial eradication |
| 02/28/2008 | US20080050429 Low flush niacin formulation |
| 02/28/2008 | US20080050428 Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic Excipient |
| 02/28/2008 | US20080050427 Analgesic combination of tramadol and meloxicam |
| 02/28/2008 | US20080050426 Herbal medicine; distillation extraction steps |
| 02/28/2008 | US20080050425 Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex |
| 02/28/2008 | US20080050424 Transdermal therapeutic system for treating parkinsonism |
| 02/28/2008 | US20080050423 Biopolymer-bioengineered cell sheet construct |
| 02/28/2008 | US20080050422 Method of administering a film product containing a drug |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050419 Epoxy-containing poly(ester amides) and method of use |
| 02/28/2008 | US20080050417 Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof |
| 02/28/2008 | US20080050414 Methods For Treating Or Preventing Restenosis And Other Vascular Proliferative Disorders |
| 02/28/2008 | US20080050407 Oral care products comprising buffer systems for improved mineralization/remineralization benefits |
| 02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
| 02/28/2008 | US20080050395 Methods for preparing and delivering adjuvant compositions |
| 02/28/2008 | US20080050352 Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose |
| 02/28/2008 | US20080050317 Oleaginous pharmaceutical and cosmetic foam |
| 02/28/2008 | US20080050310 Antibodies and immunoconjugates and uses therefor |
| 02/28/2008 | US20080047926 Method for Making Microchip Reservoir Device |
| 02/28/2008 | US20080047550 Sublingual drug delivery device |
| 02/28/2008 | DE102006040456A1 Planar solid dosage form of nutritional supplements and/or drugs, useful for the supplementation of finished or semi-finished foods, where the planar solid dosage form is e.g. cookies, cracker, soda dough products and gingerbread |
| 02/28/2008 | CA2707204A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 02/28/2008 | CA2662862A1 Treatment of aplastic anemia |
| 02/28/2008 | CA2661618A1 Stabilized pharmaceutical composition |
| 02/28/2008 | CA2661616A1 Process for preparing pramipexole dihydrochloride tablets |
| 02/28/2008 | CA2661613A1 Controlled release system and method for manufacturing the same |
| 02/28/2008 | CA2661547A1 Solid dosage form |
| 02/28/2008 | CA2661506A1 Use of a composition for skin treatment under x-irradiation |
| 02/28/2008 | CA2661377A1 Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors |
| 02/28/2008 | CA2660138A1 Galenic formulations of organic compounds |
| 02/28/2008 | CA2659914A1 Antioxidant for preventing and treating diseases caused by oxidative stress |
| 02/28/2008 | CA2659328A1 Compositions, suitable for oral administration, comprising a triazolo [4,5-d]pyrimidin derivate |
| 02/27/2008 | EP1891995A1 Drug loading of porous coating |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891963A1 Use of antagonists of PPY receptors for treating visceral pain or visceral hypersensitivity |
| 02/27/2008 | EP1891956A1 Solubilization preparation |